Value of Breast and Axillary Tumor-Infiltrating Lymphocytes for Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast Cancer
Clinical Breast Cancer · 2026-11 · 26 (11) · 17-24
DOI: 10.1016/j.clbc.2026.09.007 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Breast Cancer, 2026-11. Verfasst von Melissa Lenaerts und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - Research Institute for Oncology and Reproduction, …. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Lymphocytes, Tumor-Infiltrating, Lymph Nodes. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Health Foundation Limburg, KWF Kankerbestrijding.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands. Electronic address…
- GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands; Department of Pathology, Maastricht University Medical Center+, Maastricht, The Netherlands.
- GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlan…
- Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center+, Maastricht, The Netherlands.
- College of Medicine and Health Sciences UAE University, Al Ain, United Arab Emirates (past).
Förderung
- Stichting Health Foundation Limburg
- KWF Kankerbestrijding
Zitieren
APA
Lenaerts, M., Kooreman, L. F. S., van Amstel, F. J. G., van Diest, P. J., van Kuijk, S. M. J., Luiten, E. J. T., van der Pol, C. C., Koppert, L. B., Simons, J. M., Smidt, M. L., REFINE study group, & van Nijnatten, T. J. A. (2026). Value of Breast and Axillary Tumor-Infiltrating Lymphocytes for Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast Cancer. Clinical Breast Cancer, 26(11), 17-24. https://doi.org/10.1016/j.clbc.2026.09.007
Vancouver
Lenaerts M, Kooreman LFS, van Amstel FJG, van Diest PJ, van Kuijk SMJ, Luiten EJT, et al. Value of Breast and Axillary Tumor-Infiltrating Lymphocytes for Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast Cancer. Clinical Breast Cancer. 2026;26(11):17-24. doi:10.1016/j.clbc.2026.09.007
BibTeX
@article{Lenaerts2026,
author = {Lenaerts, Melissa and Kooreman, Loes F S and van Amstel, Florien J G and van Diest, Paul J and van Kuijk, Sander M J and Luiten, Ernest J T and van der Pol, Carmen C and Koppert, Linetta B and Simons, Janine M and Smidt, Marjolein L and REFINE study group, REFINE study group and van Nijnatten, Thiemo J A},
title = {Value of Breast and Axillary Tumor-Infiltrating Lymphocytes for Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast Cancer},
journal = {Clinical Breast Cancer},
year = {2026},
volume = {26},
number = {11},
pages = {17--24},
doi = {10.1016/j.clbc.2026.09.007}
}
EUVIMED